CONMED (CNMD) Stock: Buy, Sell, or Hold?
CNMD - CONMED Corporation
$48.13
-1.13 (-2.28%)
▼
5d:
+4.51%
30d:
+6.05%
90d:
+8.76%
HOLD
LOW Confidence
Analysis Updated: Oct 26, 2026 12:00 AM ET
Earnings: Oct 28, 2026
1d
Get Alerted When CNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNMD trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CNMD trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.34
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$32.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNMD is currently trading at $48.12, which is considered extended relative to its 30-day fair value range of $44.88 to $47.49. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.3) compared to its historical average (8.7). At these levels, the market is pricing in 6.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNMD is in a strong uptrend. Immediate support is located at $44.09, while resistance sits at $49.72.
Market Sentiment: CNMD scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNMD is in a strong uptrend. Immediate support is located at $44.09, while resistance sits at $49.72.
Market Sentiment: CNMD scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.88 -
$47.49
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
35.8%
Protect Your Profits
Holding CNMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($45.50)
- NEUTRAL: Trading at premium valuation - market expects 6.0% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$44.88 -
$47.49
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.40
(5.0%)
Support & Resistance Levels
Support Level
$44.09
Resistance Level
$49.72
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.30
Wall Street Target
$45.50
(-7.6%)
Revenue Growth (YoY)
0.3%
Earnings Growth (YoY)
11.2%
Profit Margin
4.1%
Valuation Premium vs History
+6.0% premium
PE vs Historical
10.3 vs 8.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$52.21
(+6%)
2-Year Target
$55.34
(+12%)
3-Year Target
$58.66
(+19%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$49.55
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.4%)
$111.24
(+126%)
Base:
(SPY PE: 10.3, Growth: 5.4%)
$57.69
(+17%)
Bear:
(PE: 8.7, Growth: 5.4%)
$48.73
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 26.72 | Current EPS (TTM): $1.85
Bull Case
$108.77
(+121%)
Analyst growth 100.0%, PE expands to 29.4
Base Case
$98.88
(+101%)
Market implied 100.0%, PE stable at 26.7
Bear Case
$33.62
(-32%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 26, 2026 11:46 AM ET
Data refreshes hourly during market hours. Next update: 12:46 PM
Data refreshes hourly during market hours. Next update: 12:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$101 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 35 SELL |
Advanced CNMD Option Strategies
Professional options setups generated by AI based on today's CNMD price and gamma walls.
